Metabolic complications and treatment of perinatally HIV-infected children and adolescents.
about
Perinatally infected adolescents living with human immunodeficiency virus (perinatally human immunodeficiency virus)Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challengesGetting to 90-90-90 in paediatric HIV: What is needed?Long-Term Changes of Subcutaneous Fat Mass in HIV-Infected Children on Antiretroviral Therapy: A Retrospective Analysis of Longitudinal Data from Two Pediatric HIV-Cohorts.Efficacy and safety of darunavir (Prezista(®)) with low-dose ritonavir and other antiretroviral medications in subtype F HIV-1 infected, treatment-experienced subjects in Romania: a post-authorization, open-label, one-cohort, non-interventional, proHIV treatment adherence measurement and reporting concordance in youth with perinatally acquired HIV infection and their caregiversGrowth patterns in the first year of life differ in infants born to perinatally vs. nonperinatally HIV-infected women.Cardiovascular manifestations of HIV infection in children.Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection?The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected childrenHigh Prevalence of Dyslipidemia and Insulin Resistance in HIV-infected Prepubertal African Children on Antiretroviral TherapyThe challenges of success: adolescents with perinatal HIV infection.Perinatal HIV Status and Executive Function During School-Age and Adolescence: A Comparative Study of Long-Term Cognitive Capacity Among Children From a High HIV Prevalence Setting.Immediate antiretroviral therapy in young HIV-infected children: benefits and risks.Insulin resistance in HIV-infected youth is associated with decreased mitochondrial respirationHigher subcortical and white matter cerebral blood flow in perinatally HIV-infected children.Metabolic Disorders in HIV-Infected Adolescents Receiving Protease Inhibitors.Amino Acid Concentrations in HIV-Infected Youth Compared to Healthy Controls and Associations with CD4 Counts and Inflammation.The global burden of oral diseases in pediatric HIV-infected populations: a workshop report.Association of Dyslipidemia and Glucose Abnormalities With Antiretroviral Treatment in a Cohort of HIV-Infected Latin American Children.Contributions of Disease Severity, Psychosocial Factors, and Cognition to Behavioral Functioning in US Youth Perinatally Exposed to HIV.Meeting the goal of concurrent adolescent and adult licensure of HIV prevention and treatment strategies.Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life."cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies".Dyslipidemia, chronic inflammation, and subclinical atherosclerosis in children and adolescents infected with HIV: The PositHIVe Health Study.Changes in Insulin Sensitivity over Time and Associated Factors in HIV-Infected Adolescents.A Global Research Agenda for Adolescents Living With HIV
P2860
Q26797775-0A39CC9E-EE79-4391-9783-26F81F6239D1Q27022471-78EC546D-CB76-48AB-810E-8C93B590785FQ30385352-E84BC080-F5D9-40FA-8BAB-E4D7B19CF64CQ30978868-5DFB2281-3C4A-4FBD-BB83-63FE6E765882Q34249242-45085E6E-BDDB-4084-AB8C-C68D6F5F7706Q34802665-ADB51B96-0365-432B-924F-0111B2008C73Q35078306-25EF2194-DBAC-4733-9F60-FF152A8787FBQ35422302-19ACFA4E-2929-4266-8556-C15B2FA51A66Q35984276-E2771367-3A19-4443-92DD-95F57EE5C98FQ36349683-4D23809E-7A65-4D7A-8282-DBD4C17A2FAAQ36449095-3BCC2DB3-E032-40DC-91BA-C38D713E3183Q36941673-CD8E48A1-D2CB-4A1A-8AB0-AE3BDFA98CCFQ37206362-327A7E7A-026F-4BD5-BD54-31A195E07738Q37403284-BE0585EB-93F7-4544-8D9C-965B00EA93F1Q37461232-6502AC61-B39D-478B-86D0-98D606D63988Q37656252-E954FDB9-000F-4911-B9A3-9EC69E723F02Q37673041-A8964D54-479B-4483-8CAA-19A68894B7E1Q38766457-5EAB088B-2F66-401D-841B-D5D0D3A70437Q38907470-C050BB58-9941-40B6-9966-DA11B0A57EAAQ39444280-8853AC69-CB14-403C-B60C-F8EC1CEBFC40Q39541645-AF2BFD44-FB4A-4202-BCC2-15EB1B2A8A70Q40211641-5AAFBE56-D9C5-437F-8D14-14D3A0C782CDQ41505058-CDF2D563-017E-4B91-A14C-7DF36C660053Q46698274-0EB999A2-770B-4AFE-8296-488E2909C340Q47213811-720AA4B0-EE14-4E35-B3FB-2662F7305294Q47559875-53EB810A-C28D-45D0-9831-704850CAC6C8Q57169258-B2344558-0AF5-4AEA-83A0-B9264A27376C
P2860
Metabolic complications and treatment of perinatally HIV-infected children and adolescents.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Metabolic complications and tr ...... cted children and adolescents.
@en
type
label
Metabolic complications and tr ...... cted children and adolescents.
@en
prefLabel
Metabolic complications and tr ...... cted children and adolescents.
@en
P2093
P2860
P921
P356
P1476
Metabolic complications and tr ...... cted children and adolescents.
@en
P2093
Allison Ross Eckard
Grace A McComsey
Linda Barlow-Mosha
Philippa M Musoke
P2860
P356
10.7448/IAS.16.1.18600
P5008
P577
2013-06-18T00:00:00Z